| Date Filed | Type | Description |
| 08/24/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 06/12/2023 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss... |
| 06/02/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/19/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/12/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 05/05/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/10/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/14/2023 |
SC 13G/A
| Sculptor Capital LP reports a 5.8% stake in KHOSLA VENTURES ACQUISITION CO. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 03/31/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/31/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/14/2022 |
8-K
| Quarterly results |
| 02/14/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2022 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 6.6% stake in Khosla Ventures Acquisition Co. |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2022 |
SC 13G/A
| BlackRock Inc. reports a 4.7% stake in Khosla Ventures Acquisition Co |
| 02/02/2022 |
SC 13G
| Sculptor Capital LP reports a 5.8% stake in KHOSLA VENTURES ACQUISITION CO. |
| 01/31/2022 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 3.5% stake in KHOSLA VENTURES ACQUISITION CO. III |
| 01/18/2022 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 3.8% stake in KHOSLA VENTURES ACQUISITION CO. |
| 11/29/2021 |
SC 13G
| CITADEL ADVISORS LLC reports a 6.3% stake in Khosla Ventures Acquisition Co. |
| 11/15/2021 |
8-K
| Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive ... |
| 11/09/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 11/09/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...|
Docs:
|
"Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments • Additional PIPE commitments since SPAC announcement total $33.5M • Anticipated PIPE proceeds total over $200M exceeding initial targets • New commitments made by CEO & Founder, David Berry and CFO, Graeme Bell BOSTON, MA and MENLO PARK, CA, November 9, 2021 — Valo Health, LLC , the technology company using human-centric data and artificial intelligence powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. , a special purpose acquisition company sponsored by an affiliate of Khosla Ventures, LLC , today announced that the private placement of common stock investment in connection with their previously announced business combination had expanded fro..." |
|
| 11/08/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 11/05/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/28/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/28/2021 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure... |
|